アンドログラフォリドとその誘導体の炎症性疾患における治療的可能性

Xiaoqin Shan¹, Siyi Li¹, Jiayi Liu¹

¹Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.

Pharmacology research & perspectives

|August 30, 2025

まとめ

伝統的な中国薬の成分から合成されたアンドログラフォリド派生体は,重要な抗炎症効果を示しています. 感染症,肺損傷,神経疾患などの様々な炎症症を治療する可能性を研究しています.

科学分野:

薬理学について
薬剤化学
免疫学

背景:

アンドログラフォリデは,天然の抗生物質と抗炎症性を持っています.
合成されたアンドログラフォリド誘導体は,抗炎症薬学的活性が強化されている.
アンドログラフォリドの化学的変異により,生物学的活性が異なっています.

研究の目的:

アンドログラフォリド誘導体の抗炎症メカニズムを要約する.
炎症性疾患の治療におけるアンドログラフォリド誘導体の研究の進展をレビューする.
ウイルス感染症,呼吸器/肺損傷,胃腸疾患,肝臓損傷,神経疾患におけるこれらの誘導体の治療の可能性を調査する.

主な方法:

抗炎症メカニズムと薬理学的研究の文献レビュー
ハイドロキシルと二重結合群の変化によるアンドログラフォリド誘導体の合成.
治療の可能性に関するオリジナルの研究結果を含める.

主要な成果:

アンドログラフォリド系は,広範囲の抗炎症作用を示しています.
これらの誘導体は,様々な炎症性疾患の臨床前モデルにおいて有効である.
特定の改変は,独特の薬理学的性質と治療効果と相関する.

結論:

アンドログラフォリド誘導体は,炎症性疾患の管理に有望な化合物のクラスです.
治療的な可能性に関するさらなる研究が必要である.
このレビューは,新しい抗炎症剤に関する将来の調査の根拠を提供します.

キーワード:

アンドログラフォリド抗炎症メカニズムデリバティブ炎症性疾患

さらに関連する動画

04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.2K

12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K

関連する概念動画

01:30

Adrenergic Agonists: Therapeutic Uses

943

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

943

01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

201

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

201

01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

264

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

264

01:18

Adrenergic Agonists: Therapeutic Classification

940

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...

940

01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

230

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

230

01:24

Principles of Drug Action

6.6K

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...